ACE and systolic heart failure: Two groups of PPO START cardiovascular medications had lower lift values for readmission: (1) the omission of beta blockers for patients with stable systolic heart failure (STARTA8) provided a lift = 1.46, and (2) for diabetic patients with renal disease the omission of ACE inhibitors or angiotensin II receptor antagonists (ARBs) (STARTF) provided a lift = 1.64 (Table 4).